Wei Dong Jiang
Founder at SHANGHAI HENLIUS BIOTECH, INC.
Net worth: 2 M $ as of 29/04/2024
Wei Dong Jiang active positions
| Companies | Position | Start | End |
|---|---|---|---|
| SHANGHAI HENLIUS BIOTECH, INC. | Chief Tech/Sci/R&D Officer | 30/11/2009 | - |
| Founder | 30/11/2009 | - |
Career history of Wei Dong Jiang
Former positions of Wei Dong Jiang
| Companies | Position | Start | End |
|---|---|---|---|
Henlius Biopharmaceuticals, Inc.
 Henlius Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Henlius Biopharmaceuticals, Inc. focuses on development and commercialization of mAb-based therapeutics biosimilars and biobetter for malignant tumors and auto-immune diseases. The company was founded by Scott Liu and Paul Liu in 2009 and is headquartered in Fremont, CA. | Chief Tech/Sci/R&D Officer | 31/12/2008 | - |
| Founder | 31/12/2008 | - |
Training of Wei Dong Jiang
| Zhejiang University | Undergraduate Degree |
| University of Giessen | Doctorate Degree |
Statistics
International
| China | 3 |
| United States | 2 |
| Germany | 2 |
Operational
| Chief Tech/Sci/R&D Officer | 2 |
| Founder | 2 |
| Undergraduate Degree | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| SHANGHAI HENLIUS BIOTECH, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Henlius Biopharmaceuticals, Inc.
Henlius Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Henlius Biopharmaceuticals, Inc. focuses on development and commercialization of mAb-based therapeutics biosimilars and biobetter for malignant tumors and auto-immune diseases. The company was founded by Scott Liu and Paul Liu in 2009 and is headquartered in Fremont, CA. | Health Technology |
- Stock Market
- Insiders
- Wei Dong Jiang
- Experience
